This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Innovations of Deborah Chen in Nitric Oxide Synthase Inhibition
Introduction
Deborah Chen is a notable inventor based in Wilmington, Delaware. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that inhibit nitric oxide synthase. Her work is crucial for advancing therapeutic options for various inflammatory diseases and central nervous system disorders.
Latest Patents
Deborah Chen holds a patent for "Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase." This patent describes novel compounds that are effective in treating inflammatory diseases, CNS disorders, and pain. The compounds, along with their pharmaceutically acceptable salts, are detailed in the patent, which also outlines the processes for their preparation and therapeutic applications.
Career Highlights
Deborah Chen is currently associated with AstraZeneca, a leading global biopharmaceutical company. Her role involves extensive research and development in the field of drug discovery, focusing on innovative solutions for complex health issues.
Collaborations
Some of her notable coworkers include David R. Cheshire and Stephen Connolly, who contribute to her research efforts at AstraZeneca.
Conclusion
Deborah Chen's innovative work in the field of nitric oxide synthase inhibition exemplifies the impact of scientific research on therapeutic advancements. Her contributions continue to pave the way for new treatments in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile